Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhuqing Dong

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Frontiers in Public Health|April 15, 2026
Cost-effectiveness analysis of toripalimab plus bevacizumab as first-line therapy for advanced hepatocellular carcinomaChuangao Wu, Tingfang Wei, Xingfa Ye, et al.
Journal of Inflammation Research|April 3, 2026
Mitochondrial Hub Genes in Rheumatoid Arthritis Identified by Machine Learning and Mendelian Randomization with Experimental ValidationXiaolin Luo, Zhuqing Dong, Yuansong Song, et al.
Frontiers in Pharmacology|November 10, 2025
Targeting type H vessels with bioactive metabolites from traditional Chinese botanical drugs: a therapeutic strategy for skeletal disordersShengping Tang, Jinkao Li, Zhuqing Dong, et al.
Frontiers in Physiology|March 5, 2025
Progress in understanding Legg-Calvé-Perthes disease etiology from a molecular and cellular biology perspectiveXinda Zheng, Zhuqing Dong, Xiaofei Ding, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Frontiers in Public Health|April 15, 2026
Cost-effectiveness analysis of toripalimab plus bevacizumab as first-line therapy for advanced hepatocellular carcinomaChuangao Wu, Tingfang Wei, Xingfa Ye, et al.
Journal of Inflammation Research|April 3, 2026
Mitochondrial Hub Genes in Rheumatoid Arthritis Identified by Machine Learning and Mendelian Randomization with Experimental ValidationXiaolin Luo, Zhuqing Dong, Yuansong Song, et al.
Frontiers in Pharmacology|November 10, 2025
Targeting type H vessels with bioactive metabolites from traditional Chinese botanical drugs: a therapeutic strategy for skeletal disordersShengping Tang, Jinkao Li, Zhuqing Dong, et al.
Frontiers in Physiology|March 5, 2025
Progress in understanding Legg-Calvé-Perthes disease etiology from a molecular and cellular biology perspectiveXinda Zheng, Zhuqing Dong, Xiaofei Ding, et al.
Pageof 1